Vir Biotechnology (VIR) Earnings Date, Estimates & Call Transcripts $5.65 -0.28 (-4.72%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$5.63 -0.02 (-0.42%) As of 07/11/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vir Biotechnology Earnings Summary Vir Biotechnology announced Q1 2025 earnings on May 7, 2025, reporting an EPS of -$0.88, which missed analysts' consensus estimates of -$0.83 by $0.05. Quarterly revenue fell 94.6% year-over-year to $3.03 million, below analyst estimates of $8.59 million. With a trailing EPS of -$4.22, Vir Biotechnology's earnings are expected to grow next year, from ($3.92) to ($3.55) per share. Upcoming Q2 Earnings DateJul. 30After Market ClosesEstimatedConsensus EPS (May. 7) -$0.83 Actual EPS (May. 7) -$0.88 Missed By -$0.05 Actual Revenue (May. 7) $3.03MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)VIR Upcoming EarningsVir Biotechnology's Q2 2025 earnings is scheduled for Wednesday, July 30, 2025, with a conference call scheduled on Thursday, July 31, 2025 at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Vir Biotechnology Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vir Biotechnology and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVIR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VIR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Vir Biotechnology Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.09-$0.68-$0.89Q2 20252-$0.95-$0.54-$0.75Q3 20252-$0.88-$0.54-$0.71Q4 20252-$0.87-$0.53-$0.70 FY 2025 8 -$3.79 -$2.29 -$3.04 Q1 20261-$0.53-$0.53-$0.53Q2 20261-$0.55-$0.55-$0.55Q3 20261-$0.57-$0.57-$0.57Q4 20261-$0.58-$0.58-$0.58 Vir Biotechnology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/30/2025(Estimated)--------5/7/2025Q1 2025-$0.83-$0.88 -$0.05-$0.88$8.59M$3.03M2/26/2025Q4 2024-$0.85-$0.76+$0.09-$0.76$8.14M$12.37M10/31/2024Q3 2024-$1.05-$1.56 -$0.51-$1.56$5.54M$2.38M8/1/2024Q2 2024-$0.89-$1.02 -$0.13-$1.02$7.53M$3.08M5/2/2024Q1 2024-$0.99-$0.48+$0.51-$0.48$11.71M$56.38M2/22/2024Q4 2023-$1.14-$0.86+$0.28-$0.86$11.18M$16.80M11/2/2023Q3 2023-$1.21-$1.22 -$0.01-$1.22$12.57M$2.64M8/3/2023Q2 2023-$1.21-$1.45 -$0.24-$1.45$22.39M$3.80M Vir Biotechnology Earnings - Frequently Asked Questions When is Vir Biotechnology's earnings date? Vir Biotechnology has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 30th, 2025 based off last year's report dates. Learn more on VIR's earnings history. Did Vir Biotechnology beat their earnings estimates last quarter? In the previous quarter, Vir Biotechnology (NASDAQ:VIR) missed the analysts' consensus estimate of ($0.83) by $0.05 with a reported earnings per share (EPS) of ($0.88). Learn more on analysts' earnings estimate vs. VIR's actual earnings. How can I listen to Vir Biotechnology's earnings conference call? The conference call for Vir Biotechnology's latest earnings report can be listened to online. Listen to Conference Call How can I read Vir Biotechnology's conference call transcript? The conference call transcript for Vir Biotechnology's latest earnings report can be read online. Read Transcript How much revenue does Vir Biotechnology generate each year? Vir Biotechnology (NASDAQ:VIR) has a recorded annual revenue of $74.21 million. How much profit does Vir Biotechnology generate each year? Vir Biotechnology (NASDAQ:VIR) has a recorded net income of -$521.96 million. VIR has generated -$4.22 earnings per share over the last four quarters. What is Vir Biotechnology's EPS forecast for next year? Vir Biotechnology's earnings are expected to grow from ($3.92) per share to ($3.55) per share in the next year. More Earnings Resources from MarketBeat Related Companies KYMR Earnings Results IMVT Earnings Results CRNX Earnings Results ALVO Earnings Results AMRX Earnings Results CPRX Earnings Results BHC Earnings Results OGN Earnings Results MIRM Earnings Results XENE Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:VIR) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vir Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vir Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VIR Stock Alerts